Eisai Co Ltd 4523.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
7,400.00quote price arrow up+65.00 (+0.89%)
Volume
785,600
52 week range
6,083.00 - 10,900.00

...

Loading . . .

KEY STATS

  • Open7,400.00
  • Day High7,431.00
  • Day Low7,343.00
  • Prev Close7,335.00
  • 52 Week High10,900.00
  • 52 Week High Date11/06/20
  • 52 Week Low6,083.00
  • 52 Week Low Date03/19/20
  • Market Cap19,900.34M
  • Shares Out286.69M
  • 10 Day Average Volume758,140
  • Dividend160.00
  • Dividend Yield2.16%
  • Beta
  • 1 Year % Change-7.71

RATIOS/PROFITABILITY

  • EPS (TTM)137.80
  • P/E (TTM)53.70
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/29/2020
  • Div Amount80.00
  • Split Date-
  • Split Factor-

Latest Eisai Co Ltd News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Eisai Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA...
Yasuhiko Kato
Chairman
Haruo Naito
Chief Executive Officer
Yasushi Okada
Chief Operating Officer
Ryohei Yanagi
Chief Financial Officer
Kenta Takahashi
General Counsel
Address
Eisai Main Bldg., 4-6-10, Koishikawa
Bunkyo-ku, TKY
112-8088
Japan